Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05440448 · ClinicalTrials.gov registry record · NA
Patch-free Occlusion Therapy
A NA study of Amblyopia, sponsored by Retina Foundation of the Southwest.
- Recruiting
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT05440448: Recruiting NA study of Amblyopia, sponsored by Retina Foundation of the Southwest.
NCT05440448 is a NA study of Amblyopia that is actively recruiting participants, run by Retina Foundation of the Southwest. The registered enrollment target is 68 participants, below the 163-participant average among 24 other Amblyopia trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05440448, a NA study of Amblyopia, is actively recruiting participants, sponsored by Retina Foundation of the Southwest.
- RECRUITING
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine whether a patch-free occlusion therapy leads to better visual outcomes in young children with amblyopia than standard-of-care occlusion therapy with an adhesive patch and whether this is associated with better adherence to the treatment.
Primary Outcome
change in logMAR relative to baseline
Conditions Studied
Interventions
- DEVICE Patch-free occlusion therapy
- DEVICE Adhesive patch
Study Locations (1)
Texas
- Retina Foundation - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2024-04-22 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
What NCT05440448 shows while recruiting
NCT05440448 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 163-participant average among 24 other Amblyopia trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 2 interventions - of which Patch-free occlusion therapy is the first listed.
NCT05440448 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05440448 about?
NCT05440448 is a clinical study titled "Patch-free Occlusion Therapy". The purpose of the study is to determine whether a patch-free occlusion therapy leads to better visual outcomes in young children with amblyopia than standard-of-care occlusion therapy with an adhesive patch and whether this is associated with better adherence to the treatment.
What is the current status of trial NCT05440448?
This trial is currently recruiting. It is a NA study. The enrollment target is 68 participants. The study started on 2024-04-22. Estimated completion is 2028-06-30.
What conditions does trial NCT05440448 study?
This clinical trial studies the following conditions: Amblyopia.
What interventions are being tested in trial NCT05440448?
The interventions under investigation include: Patch-free occlusion therapy (DEVICE), Adhesive patch (DEVICE).
Who is sponsoring clinical trial NCT05440448?
This trial is sponsored by Retina Foundation of the Southwest, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05440448 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amblyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05440448's enrollment target sits among peer trials
68 17th of 24 higher than 8 of 24 other Amblyopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amblyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Noninvasive Brain Stimulation in Adult Amblyopia
RECRUITING · NA
-
OCT Eccentric Fixation and Amblyopia in Children
RECRUITING · NA
-
Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games
RECRUITING · NA
-
Amblyopia Treatment for Children Aged 8 to 12 Years
RECRUITING · NA
-
Novel Amblyopia Treatment With Virtual Reality Games
RECRUITING · NA
-
Binocular Amblyopia Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI